Egyptian Arthroplasty Surgeons' Antibiotics Usage Awareness
Attitudes of Prophylactic Antibiotic Utilization During Primary Total Hip and Knee Arthroplasty Among Egyptian Joint Replacement Surgeons
1 other identifier
observational
105
1 country
1
Brief Summary
Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are procedures successfully applied to manage various end-stage chronic hip and knee diseases, such as osteoarthritis, rheumatoid arthritis, and femoral head avascular necrosis, as well as acute conditions, such as the neck of femur fractures, with excellent long-term functional outcomes. One of the devastating complications after such a procedure is periprosthetic joint infection (PJI). Various precautions are proposed to guard against such complications; one is the administration of perioperative antibiotics. However, injudicious or misuse of antibiotics could lead to the emergence of antimicrobial resistance, further complicating this matter. This is why various scientific and research organizations have proposed guidelines and a consensus for proper antibiotic use in perioperative THA and TKA surgery. Antibiotic prophylaxis during primary THA and TKA can reduce the risk of PJI and surgical site infections. However, there is a lack of consensus on the optimal dosages and duration of prophylaxis, and guidelines vary among institutions. Alternatives such as extended oral antibiotic prophylaxis and different antibiotic regimens are being explored. International research is needed to establish best practices and determine the potential risks of antibiotic prophylaxis during primary THA and TKA. Unfortunately, the investigators are unaware of such guidelines proposed by any Egyptian health authority to guide and control the proper utilization of antibiotics during orthoapedic practice in general and joint replacement surgeries (THA and TKA) in particular.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2024
CompletedFirst Posted
Study publicly available on registry
June 11, 2024
CompletedStudy Start
First participant enrolled
June 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedOctober 16, 2024
October 1, 2024
3 months
May 23, 2024
October 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
To determine the type of antibiotics administration during primary total hip and knee arthroplasty
The type of antibiotics will be determined as follows: the name of the antibiotic (brand or generic), and if single or dual antibiotics are used. These will be presented as numbers and percentages.
2 months
Secondary Outcomes (3)
To determine the dose of antibiotics administered during primary total hip and knee arthroplasty
2 months
To determine the timing of antibiotics administration during primary total hip and knee arthroplasty
2 months
To determine the length of antibiotics administration during primary total hip and knee arthroplasty
2 months
Interventions
Online Questionnaire
Eligibility Criteria
Active practicing Egyptian joint replacement surgeons
You may qualify if:
- All Egyptian registered members of the Egyptian Pelvis and Hip Society, practicing Egyptian joint replacement surgeons (performing surgeries as a leading surgeon) who are willing to participate
You may not qualify if:
- Members not listed in the E-mail directory of the society
- Surgeons refusing to participate
- Young surgeons who are not practicing independently
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- South Valley Universitylead
- Assiut Universitycollaborator
Study Sites (1)
Assuit Faculty of Medicine
Asyut, Asyut Governorate, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ahmed Abd El-Aal, MD
Assiut University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 23, 2024
First Posted
June 11, 2024
Study Start
June 15, 2024
Primary Completion
August 30, 2024
Study Completion
September 30, 2024
Last Updated
October 16, 2024
Record last verified: 2024-10